Vice President Of Business Development
Current
Nov 2024 - Present
AeroLeads people directory · profile
Gregg Davis Email & Phone Number
Vice President of Corporate Development at Affinia Therapeutics
at
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)
1 work email found
@affiniatx.com
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Vice President of Corporate Development at Affinia Therapeutics
Location
Raleigh, North Carolina, United States
Who is Gregg Davis? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Gregg Davis is listed as Vice President of Corporate Development at Affinia Therapeutics at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), based in Raleigh, North Carolina, United States. AeroLeads shows a work email signal at affiniatx.com and a matched LinkedIn profile for Gregg Davis.
Gregg Davis previously worked as Vice President of Business Development at Arcutis Biotherapeutics, Inc. (Nasdaq: Arqt) and Vice President Of Business Development at Affinia Therapeutics. Gregg Davis studied at Unc Kenan-Flagler Business School.
Company email context
Email format at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)
This section adds company-level context without repeating Gregg Davis's masked contact details.
{first_initial}{last}@affiniatx.com
86% confidence
AeroLeads found 1 current-domain work email signal for Gregg Davis. Compare company email patterns before reaching out.
Profile bio
About Gregg Davis
Biopharma executive with robust record of sourcing, analyzing, structuring, negotiating and closing deals. Success in diverse range of buy-side and sell-side transactions including drug licensing, R&D collaborations, platform technology deals, sales/marketing alliances, acquisitions and divestments. Extensive executive network in biopharma companies, investment banks and venture capital firms.Email: greggdavis64@gmail.comSelected Accomplishments• Closed 7 gene therapy deals in 6 months including therapeutics in-licensing, R&D collaborations and a company acquisition• Led a multi-faceted $1.5 billion deal for compounds and access to research that was reported at the time as the second biggest pact ever in pharma• Secured North American rights to a first indicated urology product for $50 million upfront, milestones and royalties• Wrote the confidential information memorandum, marketed the opportunity, sourced buyers, negotiated and closed a multi-million dollar business unit divestment that also saved 28 jobs and associated severance obligations• Executed an $820 million transaction for exclusive, worldwide rights for an NDA filed epilepsy drug• Out-licensed US OTC rights to proprietary drug formulation platform for $6 million upfront and future commitments• Divested ex-US rights for a marketed drug for an upfront payment of €208 million and €15 million in R&D credits• Negotiated a worldwide exclusive license for an IP estate comprised of over 50 patents representing the largest technology transfer deal in the discovery university’s 136 year history• Developed and launched 4 products including a multi-billion dollar drug, medical devices and an internet-based disease management applicationAreas of Expertiseo Selling organizational capabilities, establishing trust and building relationships necessary to close dealso Creative deal structuring to meet win-win objectives of opposing partieso Identification and alignment of incentives for long-term partnering successo Relentless pursuit of targets and tenacious negotiation for best possible termso Leadership and motivation of matrix due diligence teams and concise presentation of findingso Synthesis of large volumes of interrelated information to direct data-driven investment decisionso Strategic acumen and quantitative skills including knowledge of complex valuation modeling techniques
Listed skills include Strategy, Biotechnology, Market Analysis, Commercialization, and 33 others.
Current workplace
Gregg Davis's current company
Company context helps verify the profile and gives searchers a useful next step.
Arcutis Biotherapeutics, Inc. (Nasdaq: Arqt)
AeroLeads page
14 roles · 37 years
Gregg Davis work experience
A career timeline built from the work history available for this profile.
Vice President Of Business Development
Feb 2022 - Nov 2024
Vice President Of Corporate Development
Dec 2020 - Mar 2022
Vice President Of Corporate Development
Dec 2020 - Mar 2022
Vice President Of Business Development
Head of Business Development team responsible for: > In-licensing, out-licensing, R&D collaborations, acquisitions and divestments > Contract manufacturing for gene therapy plasmids and AAV vectors > Developed and drove adoption of multi-disciplined due diligence process > Closed 7 transactions in first 6 months including R&D collaborations, licensing.
Jul 2019 - Dec 2020
Vice President Of Corporate And Business Development
Avadel Pharmaceuticals Plc
Executive committee member leading Avadel's corporate development and business development activities to execute a refocused specialty pharma strategy. Responsible for sourcing and managing in-licensing, out-licensing and M&A transactions to align the company pipeline with the corporate strategy and to grow commercial capabilities.
Jun 2015 - Jul 2019
Chief Business Officer
Flag Therapeutics
Co-founded FLAG Therapeutics and negotiated the license agreement for two novel classes of oncology compounds that serves as the foundation of the company. Involved in all aspects of launching the company including development of collateral material (business plan, investor presentations, web site, etc.), initiating and participating in fund raising.
Jan 2013 - Jun 2015
Vp Corporate Development
Responsible for identifying and evaluating strategic growth opportunities for the Company and executing transactions. Lead negotiator for facilities acquisitions, bolt-on business acquisitions, technology acquisitions/licenses and strategic alliances.
Apr 2010 - Oct 2012
Director Of Worldwide Business Development
Represented GSK in business development activities including creating and delivering capabilities presentations to potential partners; coordinating commercial due diligence; managing large, cross functional matrix teams; conducting financial analysis; structuring deals; completing investment memoranda including BOD papers to secure senior management.
2002 - 2010
~8 yrs
Principal
Eno River Capital
Responsible for all facets of the due diligence process including reference checks and assessment of management teams, market research, preliminary technology assessment and financial analysis. Involved in structuring deals, writing and negotiating term sheets and syndicating deals.Extensively involved with portfolio companies including product.
1999 - 2001
~2 yrs
Product Manager
Amira Medical
Developed the forecast model for Amira’s painless blood glucose monitor along strategic and tactical sales and marketing plan that were used to raise $12.5 million in venture capital. Conducted due diligence using both original and published market research and interviews with industry experts. Designed and conducted original market research including.
1998 - 1999
~1 yr
Marketing Manager; National Accounts Manager
Enact Health Management Systems
Developed the revenue forecast model and marketing plan for a health monitoring device and information service for respiratory disorders. Forecast served as the basis for two rounds financing totaling nearly $30 million. Spearheaded effort to redefine Enact’s business model to focus on an internet-based product with sophisticated data capture and.
1996 - 1998
~2 yrs
Assistant Product Manager
Burroughs Wellcome
Assessed new pharmaceutical compounds and technologies to prioritize projects, determine funding and identify opportunities. Analyzed commercial potential for research projects and licensing opportunities. Completed commercial assessments including competitive outlook for existing and emerging technologies, interviews with physicians to determine unmet.
1993 - 1995
~2 yrs
Hospital Sales Specialist; Field Sales Representative
1989 - 1991
~2 yrs
2 education records
Gregg Davis education
Education record
Unc Kenan-Flagler Business School
Ba, Mba, Economics, Business
University Of North Carolina At Chapel Hill
FAQ
Frequently asked questions about Gregg Davis
Quick answers generated from the profile data available on this page.
What company does Gregg Davis work for?
Gregg Davis works for Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT).
What is Gregg Davis's role at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)?
Gregg Davis is listed as Vice President of Corporate Development at Affinia Therapeutics at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT).
What is Gregg Davis's email address?
AeroLeads has found 1 work email signal at @affiniatx.com for Gregg Davis at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT).
Where is Gregg Davis based?
Gregg Davis is based in Raleigh, North Carolina, United States while working with Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT).
What companies has Gregg Davis worked for?
Gregg Davis has worked for Arcutis Biotherapeutics, Inc. (Nasdaq: Arqt), Affinia Therapeutics, Beyondspring, Seed Therapeutics, and Asklepios Biopharmaceutical, Inc. (Askbio).
How can I contact Gregg Davis?
You can use AeroLeads to view verified contact signals for Gregg Davis at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), including work email, phone, and LinkedIn data when available.
What schools did Gregg Davis attend?
Gregg Davis studied at Unc Kenan-Flagler Business School.
What skills is Gregg Davis known for?
Gregg Davis is listed with skills including Strategy, Biotechnology, Market Analysis, Commercialization, Business Development, Negotiation, Financial Analysis, and Cross Functional Team Leadership.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial